| |
|
|
|
Rigel Pharmaceuticals- Inc.  
|
|
3.18 -0.01 (-0%) |
06-22 16:00 |
|
Open: |
3.26 |
Pre close: |
3.19 |
Target:
|
4.32 
|
|
High: |
3.28 |
Low: |
3.015 |
Resistance:
|
3.70
4.12
|
|
Volume: |
4,588,355 |
Market Cap: |
520M |
Support:
|
3.02
2.51
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.17
|
MACD |
MACD(12,26):
|
-0.15  |
|
MA(20): |
3.38 |
Signal(12,26,9): |
-0.14 |
|
MA(100): |
3.74 |
Stochastic Oscillator |
%K(14,3):
|
16.29 |
|
MA(250): |
3.45 |
%D(3): |
13.13 |
|
Average Volume(K) |
3-Month: |
379466
|
52-Week |
High:
|
4.71 |
|
10-Days: |
407934 |
Low: |
2.14 |
|
RSI |
RSI(14):
|
38.01 |
Change(%): |
11.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.650 |
Return on Equity (ttm) |
-98.3 |
Shares Out. (M) |
163.58 |
|
EPS Est. Current Year |
-0.600 |
Return on Assets (ttm) |
-80.6 |
Shares Float (M) |
163.27 |
|
EPS Est. Next Year |
-0.430 |
PEG Ratio |
-0.07 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.150 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
87.10 |
|
Forward EPS |
-0.470 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
7943 |
|
Book Value (p.s.) |
6.740 |
EBITDA (p.s.) |
-0.226 |
P/E |
-4.89 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.47 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-80.19 |
P/S |
52018442240.00 |
|
Operating Margin |
-9794.22 |
Levered Free Cash Flow
(M) |
-47.78 |
P/CF |
-6.49 |
|
|
|
|
|
|
